- Home
- IKT vs MX Comparison
IKT vs MX Comparison
Compare IKT & MX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- MX
- Stock Information
- Founded
- IKT 2008
- MX 2003
- Country
- IKT United States
- MX South Korea
- Employees
- IKT N/A
- MX N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- MX Semiconductors
- Sector
- IKT Health Care
- MX Technology
- Exchange
- IKT Nasdaq
- MX Nasdaq
- Market Cap
- IKT 140.5M
- MX 145.3M
- IPO Year
- IKT 2020
- MX N/A
- Fundamental
- Price
- IKT $1.71
- MX $2.97
- Analyst Decision
- IKT Buy
- MX Strong Buy
- Analyst Count
- IKT 2
- MX 2
- Target Price
- IKT $8.00
- MX $5.75
- AVG Volume (30 Days)
- IKT 117.1K
- MX 392.4K
- Earning Date
- IKT 08-26-2025
- MX 07-31-2025
- Dividend Yield
- IKT N/A
- MX N/A
- EPS Growth
- IKT N/A
- MX N/A
- EPS
- IKT N/A
- MX N/A
- Revenue
- IKT N/A
- MX $234,243,000.00
- Revenue This Year
- IKT N/A
- MX N/A
- Revenue Next Year
- IKT N/A
- MX $7.05
- P/E Ratio
- IKT N/A
- MX N/A
- Revenue Growth
- IKT N/A
- MX 16.02
- 52 Week Low
- IKT $1.12
- MX $2.51
- 52 Week High
- IKT $4.20
- MX $5.16
- Technical
- Relative Strength Index (RSI)
- IKT 49.23
- MX 34.59
- Support Level
- IKT $1.42
- MX $2.67
- Resistance Level
- IKT $1.83
- MX $4.28
- Average True Range (ATR)
- IKT 0.15
- MX 0.19
- MACD
- IKT 0.00
- MX -0.09
- Stochastic Oscillator
- IKT 62.11
- MX 18.63
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.